Lysin Plyss2 (streptococcus Suis Phage)
Lysin Plyss2 (streptococcus Suis Phage) Uses, Dosage, Side Effects, Food Interaction and all others data.
Lysin Plyss2 (streptococcus Suis Phage) is under investigation in clinical trial NCT03163446 (Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia).
| Trade Name | Lysin Plyss2 (streptococcus Suis Phage) |
| Generic | Exebacase |
| Exebacase Other Names | Des-met1-putative phage lysin (streptococcus phage phi891591), produced in escherichia coli, Exebacase, Lysin cf-301 (streptococcus suis phage), Lysin plyss2 (streptococcus suis phage) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lysin Plyss2 (streptococcus Suis Phage)
